Dr. Hector Juan Marchand Jr., MD

Dr. Marchand practices at Porter Physician Services in Valparaiso, Indiana.

Dr. Marchand's NPI, 1134474091, was assigned on July 17, 2012. Dr. Marchand graduated from Ponce School of Medicine in 2012. Dr. Marchand holds Indiana license 01075518A.

Dr. Marchand's primary practice is Porter Physician Services, at 1231 Cumberland Crossing Dr, Valparaiso, IN 46383 in Porter County. The practice phone is (219) 983-6380.

Dr. Marchand's primary practice is Porter Physician Services in Valparaiso, Indiana. Dr. Marchand is also affiliated with Northwest Health - Porter. The medical group on file is RUSH Physical Therapy. Dmand AI also links Dr. Marchand to 5 more hospitals, 5 home health agencies, 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Marchand practices, 13 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Marchand's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dmand AI has Dr. Marchand's licenses on file in 2 states: Indiana and Michigan.

CMS data shows 5,365 Medicare services from Dr. Marchand across 23 procedure codes in 2024, for 759 Medicare patients. Medicare paid $250,407 for them. Every service was in an office.

CMS counts 759 Medicare patients who saw Dr. Marchand in 2024. The largest group is 65 to 74, with 341 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 3% are also on Medicaid. Their average risk score is 1.14, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Marchand's median patient age at 73, with 54% women.

In 2024, Dr. Marchand wrote 16,832 Medicare Part D claims for 1,082 patients. 88% of them were for generic drugs. CMS names the drug for 15,849 of them, across 180 drugs with 11 or more claims each, at $1,693,928 in total drug cost. In 2023, CMS named 15,451 claims across 174 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Marchand for performance year 2024, reported through an alternative payment model (APM). Dr. Marchand accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Marchand as offering telehealth.

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 1,248 general payments to Dr. Marchand from 70 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 80% of the total. Novartis Pharmaceuticals Corporation paid the most, $6,768.

Dr. Marchand graduated from Ponce School of Medicine in 2012.